Enter the vial size and the bacteriostatic water you added to get the concentration and the micrograms carried by each unit on a U-100 syringe. Pinealon's compound page states no dose and no route, so this page does the arithmetic, not the recommendation. The compound itself is covered in the Pinealon guide.
A 20 mg vial of Pinealon reconstituted with 2 mL of bacteriostatic water gives a concentration of 10 mg/mL, or 100 mcg per unit on a U-100 syringe.
Defaults: 20 mg is the most common labelled vial among the Pinealon tests on file, 21 Sep 2026 (36 of 71); 2 mL was chosen for simple arithmetic and is not a sourced volume. Peptigrity publishes no Pinealon dose, so the dose field starts empty.
Draw the syringe up to
Enter your own amount to see the draw. Add 2 mL of water to your 20 mg vial first.
Pinealon has 71 independent lab tests on file at Peptigrity, averaging 99.54% HPLC purity across the tests that report one. Purity is not net content: a clean certificate confirms what is in a vial, not how much. See the Pinealon lab-test records.
Pinealon is a synthetic tripeptide (Glu-Asp-Arg) from the Khavinson bioregulator family, researched for pineal-gland-targeted neuroprotection, cognitive preservation and melatonin pathway regulation. The evidence is preclinical rodent and cell-culture work plus Khavinson-group human research in Russian clinical contexts, which the compound page says is not characterized at FDA-grade Phase 2/3 standards. Asked whether Peptigrity recommends a Pinealon dose, the page answers no. A calculator that printed one would be inventing the number the evidence does not supply.
The table sets out what the Pinealon compound page states (Last Updated: August 2026).
| Question | What the compound page states | Evidence level |
|---|---|---|
| What is it? | A synthetic tripeptide (Glu-Asp-Arg) from the Khavinson bioregulator family, with a defined three-amino-acid sequence | Chemical identity |
| Proposed target? | Pineal gland: neuroprotection, cognitive preservation and melatonin pathway regulation | Khavinson-framework proposal |
| Human studies? | Human research in Russian clinical contexts, not characterized at FDA-grade Phase 2/3 standards | Preclinical (rodent and cell culture); Khavinson-group human research |
| A route? | Not stated. The side-effects paragraph mentions injection-site reactions among community reports; that is safety text, not a route statement | None stated |
| An approved dose? | Not approved by the FDA, EMA, or any major Western regulator (as of August 2026) | None |
| A research dose? | None stated; Peptigrity does not recommend one | None — declined |
One practical consequence: a milligram of Pinealon and a milligram of another short Khavinson peptide look the same to a calculator. The compound page gives the free tripeptide's molecular weight as 418.4 Da and warns that related Khavinson tripeptides can be mislabeled, so only a mass-spectrometry result on a certificate confirms which peptide a vial holds. The arithmetic also works from the label, not the contents: the Pinealon fact sheet records 69 results comparing measured to labelled quantity, with a median of 102.1% of label (figures as of 2026-09-21).
The table converts reference quantities to syringe units at the default of 10 mg/mL (20 mg of Pinealon in 2 mL), and counts how many draws of each a vial holds. Every row is arithmetic, not a dose: read the units for the amount you already intend to measure.
| Quantity | Draw at 10 mg/mL | Volume | Draws from a 10 mg vial | Draws from a 20 mg vial |
|---|---|---|---|---|
| 100 mcg | 1.0 units | 0.01 mL | 100 | 200 |
| 250 mcg | 2.5 units | 0.025 mL | 40 | 80 |
| 500 mcg | 5.0 units | 0.05 mL | 20 | 40 |
| 1 mg | 10.0 units | 0.10 mL | 10 | 20 |
| 2 mg | 20.0 units | 0.20 mL | 5 | 10 |
The same Pinealon quantity lands on a different mark depending on how much water went into the vial. Read down the column for the concentration you actually mixed; a units figure carried across from another column is simply wrong.
| Quantity | At 20 mg/mL (20 mg + 1 mL) | At 10 mg/mL (20 mg + 2 mL) | At 4.0 mg/mL (20 mg + 5 mL) |
|---|---|---|---|
| 100 mcg | 0.5 units | 1.0 units | 2.5 units |
| 250 mcg | 1.3 units | 2.5 units | 6.3 units |
| 500 mcg | 2.5 units | 5.0 units | 12.5 units |
| 1 mg | 5.0 units | 10.0 units | 25.0 units |
| 2 mg | 10.0 units | 20.0 units | 50.0 units |
Every cell is the same arithmetic: units = (quantity in mg ÷ concentration in mg/mL) × 100 on a U-100 syringe. More water spreads the same mass over more units, which is the fix when a small quantity would otherwise sit at two or three units, where a one-unit misread is a large error.
Each Pinealon vial holds as many draws as its labelled mass divided by the quantity per draw; the water volume changes nothing about it. The grid counts draws, not weeks — this page states no frequency.
| Vial size | At 100 mcg | At 250 mcg | At 500 mcg | At 1 mg | At 2 mg |
|---|---|---|---|---|---|
| 10 mg | 100 | 40 | 20 | 10 | 5 |
| 20 mg | 200 | 80 | 40 | 20 | 10 |
The labelled mass is not a guarantee of the mass in your vial: net content is a separate measurement from purity, and certificates on file often measure a few percent above or below the label.
No label sets a diluent volume for research-grade Pinealon, and the compound page states none, so the volume is a choice; the 2 mL default here was picked for simple arithmetic. The one decision with real consequences is resolution: a 20 mg vial in 2 mL is 10 mg/mL, where each unit carries 100 mcg and a small quantity sits at one or two units. The fix is more water: 5 mL in the same vial is 4 mg/mL, or 40 mcg per unit. The technique is covered once, elsewhere: reconstituting peptides step by step and the bacteriostatic water guide. Storage and in-use guidance there is general peptide guidance, not a Pinealon-specific finding.
Pinealon, Cartalax and Testagen share one calculator template. The table gives each one's structure and proposed target as its own compound page states them (each Last Updated: August 2026), and the most common labelled vial among its tests on file on 21 Sep 2026.
| Compound | Structure | Proposed target tissue | Most common labelled vial | Calculator |
|---|---|---|---|---|
| Pinealon | Tripeptide (Glu-Asp-Arg) | Pineal / brain | 20 mg (36 of 71 tests) | This page |
| Cartalax | Tripeptide (Ala-Glu-Asp) | Cartilage / connective tissue | 20 mg (37 of 52 tests) | Cartalax calculator |
| Testagen | Tetrapeptide (Lys-Glu-Asp-Gly) | Testis / reproductive | 20 mg (18 of 22 tests) | Testagen calculator |
None of the three compound pages states a dose or a route. Because the vials share a size, the arithmetic is the same for each; what differs is identity, which only mass spectrometry settles. The Pinealon page pairs it with Epithalon, the pineal-targeted tetrapeptide (Ala-Glu-Asp-Gly), which has its own Epithalon calculator. The wider family is in the bioregulators category and the science of Khavinson bioregulators.
Pinealon is not approved by the FDA, EMA, or any major Western regulator as of August 2026. The compound page states it is not on the FDA's active Section 503A/503B Category-2 bulk-substances list and was not among the peptides the FDA addressed in its April 2026 Category-2 actions or the July 2026 Pharmacy Compounding Advisory Committee meeting, so no U.S. compounding pathway applies to it. It is used in Russian clinical and research contexts but has no defined Western regulatory pathway. Background: FDA peptide regulation 2025–2026.
Independent test records: Pinealon lab tests. Tracked prices: Pinealon price per milligram.
It depends on the concentration. At the page default of 10 mg/mL (a 20 mg vial with 2 mL of water), each unit on a U-100 syringe carries 100 mcg, so 500 mcg is 5 units (0.05 mL). A 10 mg vial with the same 2 mL is 5 mg/mL, and 500 mcg is 10 units. A units figure quoted without a concentration cannot be used.
There isn't one. Pinealon is not approved by any major Western regulator, its human research comes from Khavinson-group work in Russian clinical contexts rather than FDA-grade Phase 2/3 trials, and Peptigrity does not recommend a dose. This calculator converts a quantity you already have in mind into syringe units; it does not supply the quantity.
No. Both are Khavinson bioregulators targeting pineal tissue, but Pinealon is a tripeptide (Glu-Asp-Arg) proposed for neuroprotection and cognitive markers, while Epithalon is a tetrapeptide (Ala-Glu-Asp-Gly) proposed for telomerase activation. They are different molecules with different sequences, and only mass spectrometry on a certificate tells them apart in a vial.
The Pinealon compound page states no route. Its side-effects paragraph says injection-site reactions are the most common report in preclinical data and community-reported research use; that is safety text, not a route statement, and this page does not treat it as one. The calculator converts the mass in a reconstituted vial into syringe units because that is the arithmetic people ask for; it establishes nothing about route.
Because 20 mg is the most common labelled size among the Pinealon tests on file at Peptigrity: 36 of 71 on 21 Sep 2026, with 10 mg the next most common. The 2 mL of water is a round number chosen for simple arithmetic, not a sourced instruction.
With an independent certificate of analysis: HPLC for purity and mass spectrometry for identity. The compound page gives the free tripeptide's molecular weight as 418.4 Da; mass spectrometry is what distinguishes Pinealon from other short Khavinson peptides that can be mislabeled.